Article
5' splice site GC>GT and GT>GC variants differ markedly in terms of their functionality and pathogenicity.
Human mutation - 1 Aug 2020
Lin Jin-Huan, Masson Emmanuelle, Boulling Arnaud, Hayden Matthew, Cooper David N, Férec Claude, Liao Zhuan, Chen Jian-Min
Abstract excerpt
In the human genome, most 5' splice sites (~99%) employ the canonical GT dinucleotide whereas a small minority (~1%) use the noncanonical GC dinucleotide. The functionality and pathogenicity of 5' splice site GT>GC (+2T>C) variants have been extensively studied but we know very little about 5' splice site GC>GT (+2C>T) variants. Herein, we have addressed this deficiency by performing a meta-analysis of reported...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
